Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
25277 | 286 | 31.8 | 59% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
285 | 3 | ERDOSTEINE//PEROXIREDOXIN//GLUTATHIONE | 42405 |
2650 | 2 | EXTRACELLULAR SUPEROXIDE DISMUTASE//SUPEROXIDE DISMUTASE//SOD MIMIC | 3470 |
25277 | 1 | ORGOTEIN//ENDOGENOUS ANTIOXIDANT DEFENCE//LECITHINIZED SUPEROXIDE DISMUTASE PC SOD | 286 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ORGOTEIN | authKW | 384355 | 2% | 60% | 6 |
2 | ENDOGENOUS ANTIOXIDANT DEFENCE | authKW | 320300 | 1% | 100% | 3 |
3 | LECITHINIZED SUPEROXIDE DISMUTASE PC SOD | authKW | 320300 | 1% | 100% | 3 |
4 | MELON EXTRACT | authKW | 320300 | 1% | 100% | 3 |
5 | LECITHINIZED SUPEROXIDE DISMUTASE | authKW | 320294 | 2% | 50% | 6 |
6 | P INFECT ONCOL | address | 244035 | 1% | 57% | 4 |
7 | LECITHINIZED BDNF | authKW | 213533 | 1% | 100% | 2 |
8 | MELON CONCENTRATE | authKW | 213533 | 1% | 100% | 2 |
9 | UNMODIFIED SOD U SOD | authKW | 213533 | 1% | 100% | 2 |
10 | ENZYMOSOMES | authKW | 192178 | 1% | 60% | 3 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Rheumatology | 576 | 8% | 0% | 24 |
2 | Pharmacology & Pharmacy | 425 | 24% | 0% | 69 |
3 | Respiratory System | 139 | 6% | 0% | 18 |
4 | Biochemistry & Molecular Biology | 108 | 20% | 0% | 57 |
5 | Physiology | 69 | 6% | 0% | 18 |
6 | Biophysics | 52 | 6% | 0% | 17 |
7 | Nutrition & Dietetics | 26 | 3% | 0% | 9 |
8 | Endocrinology & Metabolism | 25 | 5% | 0% | 14 |
9 | Chemistry, Medicinal | 24 | 3% | 0% | 10 |
10 | Medicine, Research & Experimental | 23 | 5% | 0% | 13 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | P INFECT ONCOL | 244035 | 1% | 57% | 4 |
2 | UMR PREVENT MALNUTR PATHOL ASSOCIEES 204 | 142350 | 1% | 33% | 4 |
3 | ANESZTEZIOL INTENS TER IAS | 106767 | 0% | 100% | 1 |
4 | DRUGS OSAKA BRANCH 1143 HOENZAKA CHUO KU | 106767 | 0% | 100% | 1 |
5 | EA 3762 NUTR ALIMENTS | 106767 | 0% | 100% | 1 |
6 | EA CPID 7288 | 106767 | 0% | 100% | 1 |
7 | ENDOCRINOL CAROL DAVILA | 106767 | 0% | 100% | 1 |
8 | FOOD SCI BIOACT HLTH LS9 | 106767 | 0% | 100% | 1 |
9 | FRONTIER MED MED SCI | 106767 | 0% | 100% | 1 |
10 | H HUMAN ENVIRONM | 106767 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | EUROPEAN JOURNAL OF RHEUMATOLOGY AND INFLAMMATION | 66710 | 3% | 6% | 10 |
2 | JAPANESE JOURNAL OF CLINICAL MEDICINE | 26690 | 0% | 25% | 1 |
3 | MOLECULAR PHYSIOLOGY | 10582 | 2% | 2% | 5 |
4 | FREE RADICAL RESEARCH COMMUNICATIONS | 1426 | 1% | 0% | 3 |
5 | ACTA RADIOLOGICA ONCOLOGY | 951 | 1% | 0% | 2 |
6 | JOURNAL OF CONTROLLED RELEASE | 908 | 3% | 0% | 8 |
7 | JOURNAL OF ORTHOPAEDIC RHEUMATOLOGY | 888 | 0% | 1% | 1 |
8 | FOLIA PHARMACOLOGICA JAPONICA | 869 | 1% | 0% | 3 |
9 | RHEUMATOLOGY AND REHABILITATION | 819 | 0% | 1% | 1 |
10 | ZEITSCHRIFT FUR RHEUMATOLOGIE | 726 | 1% | 0% | 4 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ORGOTEIN | 384355 | 2% | 60% | 6 | Search ORGOTEIN | Search ORGOTEIN |
2 | ENDOGENOUS ANTIOXIDANT DEFENCE | 320300 | 1% | 100% | 3 | Search ENDOGENOUS+ANTIOXIDANT+DEFENCE | Search ENDOGENOUS+ANTIOXIDANT+DEFENCE |
3 | LECITHINIZED SUPEROXIDE DISMUTASE PC SOD | 320300 | 1% | 100% | 3 | Search LECITHINIZED+SUPEROXIDE+DISMUTASE+PC+SOD | Search LECITHINIZED+SUPEROXIDE+DISMUTASE+PC+SOD |
4 | MELON EXTRACT | 320300 | 1% | 100% | 3 | Search MELON+EXTRACT | Search MELON+EXTRACT |
5 | LECITHINIZED SUPEROXIDE DISMUTASE | 320294 | 2% | 50% | 6 | Search LECITHINIZED+SUPEROXIDE+DISMUTASE | Search LECITHINIZED+SUPEROXIDE+DISMUTASE |
6 | LECITHINIZED BDNF | 213533 | 1% | 100% | 2 | Search LECITHINIZED+BDNF | Search LECITHINIZED+BDNF |
7 | MELON CONCENTRATE | 213533 | 1% | 100% | 2 | Search MELON+CONCENTRATE | Search MELON+CONCENTRATE |
8 | UNMODIFIED SOD U SOD | 213533 | 1% | 100% | 2 | Search UNMODIFIED+SOD+U+SOD | Search UNMODIFIED+SOD+U+SOD |
9 | ENZYMOSOMES | 192178 | 1% | 60% | 3 | Search ENZYMOSOMES | Search ENZYMOSOMES |
10 | PC SOD | 192178 | 1% | 60% | 3 | Search PC+SOD | Search PC+SOD |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | CARILLON, J , ROUANET, JM , CRISTOL, JP , BRION, R , (2013) SUPEROXIDE DISMUTASE ADMINISTRATION, A POTENTIAL THERAPY AGAINST OXIDATIVE STRESS RELATED DISEASES: SEVERAL ROUTES OF SUPPLEMENTATION AND PROPOSAL OF AN ORIGINAL MECHANISM OF ACTION.PHARMACEUTICAL RESEARCH. VOL. 30. ISSUE 11. P. 2718-2728 | 38 | 44% | 27 |
2 | MUZYKANTOV, VR , (2001) DELIVERY OF ANTIOXIDANT ENZYME PROTEINS TO THE LUNG.ANTIOXIDANTS & REDOX SIGNALING. VOL. 3. ISSUE 1. P. 39 -62 | 40 | 22% | 29 |
3 | MIZUSHIMA, T , (2014) DEVELOPMENT OF LECITHINIZED SUPEROXIDE DISMUTASE AS A DRUG FOR IPF.YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN. VOL. 134. ISSUE 1. P. 69 -76 | 7 | 88% | 0 |
4 | SKOLMOWSKA, M , KMIEC, M , (2011) ANTIOXIDANT ENZYMOSOMES - PROPERTIES AND APPLICATION.POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ. VOL. 65. ISSUE . P. 640 -644 | 12 | 52% | 2 |
5 | JADOT, G , VAILLE, A , MALDONADO, J , VANELLE, P , (1995) CLINICAL PHARMACOKINETICS AND DELIVERY OF BOVINE SUPEROXIDE-DISMUTASE.CLINICAL PHARMACOKINETICS. VOL. 28. ISSUE 1. P. 17-25 | 12 | 71% | 53 |
6 | EUGENIA, M , CRUZ, M , GASPAR, MM , MARTINS, MBF , CORVO, ML , (2005) LIPOSOMAL SUPEROXIDE DISMUTASES AND THEIR USE IN THE TREATMENT OF EXPERIMENTAL ARTHRITIS.LIPOSOMES, PT E. VOL. 391. ISSUE . P. 395 -413 | 9 | 53% | 22 |
7 | GASPAR, MM , BOERMAN, OC , LAVERMAN, P , CORVO, ML , STORM, G , CRUZ, MEM , (2007) ENZYMOSOMES WITH SURFACE-EXPOSED SUPEROXIDE DISMUTASE: IN VIVO BEHAVIOUR AND THERAPEUTIC ACTIVITY IN A MODEL OF ADJUVANT ARTHRITIS.JOURNAL OF CONTROLLED RELEASE. VOL. 117. ISSUE 2. P. 186-195 | 12 | 35% | 21 |
8 | CARILLON, J , NOTIN, C , SCHMITT, K , SIMONEAU, G , LACAN, D , (2014) DIETARY SUPPLEMENTATION WITH A SUPEROXIDE DISMUTASE-MELON CONCENTRATE REDUCES STRESS, PHYSICAL AND MENTAL FATIGUE IN HEALTHY PEOPLE: A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL.NUTRIENTS. VOL. 6. ISSUE 6. P. 2348 -2359 | 8 | 44% | 2 |
9 | FLOHE, L , (1988) SUPEROXIDE-DISMUTASE FOR THERAPEUTIC USE - CLINICAL-EXPERIENCE, DEAD ENDS AND HOPES.MOLECULAR AND CELLULAR BIOCHEMISTRY. VOL. 84. ISSUE 2. P. 123-131 | 13 | 59% | 80 |
10 | ROMAO, S , (2015) THERAPEUTIC VALUE OF ORAL SUPPLEMENTATION WITH MELON SUPEROXIDE DISMUTASE AND WHEAT GLIADIN COMBINATION.NUTRITION. VOL. 31. ISSUE 3. P. 430 -436 | 11 | 31% | 2 |
Classes with closest relation at Level 1 |